VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Strong Trading Volume

Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) saw strong trading volume on Friday . 111,488 shares changed hands during mid-day trading, a decline of 19% from the previous session’s volume of 137,580 shares.The stock last traded at $94.63 and had previously closed at $94.47.

VanEck Pharmaceutical ETF Stock Performance

The firm has a market cap of $622.90 million, a P/E ratio of 21.04 and a beta of 0.72. The firm has a 50 day simple moving average of $91.79 and a 200 day simple moving average of $89.32.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, July 5th. Stockholders of record on Monday, July 1st were given a dividend of $0.3558 per share. The ex-dividend date of this dividend was Monday, July 1st.

Institutional Trading of VanEck Pharmaceutical ETF

Large investors have recently modified their holdings of the business. Avestar Capital LLC bought a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter valued at about $4,284,000. Raymond James Financial Services Advisors Inc. lifted its position in VanEck Pharmaceutical ETF by 462.4% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 18,148 shares of the company’s stock worth $1,477,000 after buying an additional 14,921 shares during the last quarter. Independent Advisor Alliance lifted its position in VanEck Pharmaceutical ETF by 100.8% in the 4th quarter. Independent Advisor Alliance now owns 98,473 shares of the company’s stock worth $7,939,000 after buying an additional 49,423 shares during the last quarter. Private Client Services LLC bought a new stake in VanEck Pharmaceutical ETF in the 4th quarter worth approximately $298,000. Finally, Assetmark Inc. lifted its position in VanEck Pharmaceutical ETF by 107.5% in the 4th quarter. Assetmark Inc. now owns 5,485 shares of the company’s stock worth $446,000 after buying an additional 2,841 shares during the last quarter.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.